None listed
Conditions
Interventions
None listed
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Aged from 20 to 69 2) Body mass index (BMI) ranged from 18.0 to 25 kg/m2 3) Healthy control group: glomerular filtration rate (GFR) is greater than 90 ml/min/1.73m2 4) Chronic kidney disease (CKD) patient group: GFR is less than 60 ml/min/1.73m2 5) Subjects or legal surrogates who signed an informed consent after the full explanation for the purpose of the study.
Exclusion criteria
Exclusion criteria: 1) Common ? Thyroid/endocrine system disorder or history of endocrine disease ? Cardiovascular disease(heart failure, angina pectoris and myocardial infarction) ? History of malignant neoplasm or express complication due to maligant neoplasm (possible if no relapse for the past 5 years) ? Severe liver disease, blood disease, respiration disease, disease of digestive system, and brain disease. ? Pregnancy, nursing mother, or having the history of any contraceptives. ? Mental disorder: depression, anxiety neurosis, schizophrenia, eating disorder, continuous drug use. ? Drug or alcohol abuse. ? Equipped pace maker or any electric device transplants. ? Involving vigorous-intensity activity or exercise more than an hour within a week. ? Deformity or neoplasm on the tongue ? Sensitive reaction to the general laboratory tests. ? Current smoker. ? Refusal to the informed contents. ? Regarded as inappropriate subjects by means of the discretion of the principal or research investigators. 2) Healthy control ? Hypertension (systolic blood pressure is greater than 140 mmHg or diastolic blood pressure is greater than 90 mmHg). ? Fasting blood glucose (FBG) is greater than 140 mg/dl or non-insulin dependent diabetes mellitus. 3) CKD patients group ? History of hemodialysis or peritoneal dialysis from the past one years before obtaining the informed content. ? Patients who scheduled to get the kidney transplant operation or peritoneal dialysis within 24 weeks after obtaining the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total resistance measured at 5/50/250 kHz | — |
Secondary
| Measure | Time frame |
|---|---|
| InBody S-10 measures;Skin resistance measuring device 1 (DDFA) measures;Skin resistance measuring device 2 (Rebon Skin Check: RSC) measures;Upper-arm edema characteristic measures;laboratory test measures | — |
Countries
Korea, Republic of
Contacts
Public ContactHyerin Kwon
Gachon University Gil Medical Center
Outcome results
None listed